Page 310 - Computational Modeling in Biomedical Engineering and Medical Physics

Index 299

K from larger blood vessel to region of interest,
Kidney, 254 199 210
CAD abstraction of, 72 73 through membrane and tissue, 204 210
Kinematic viscosity, 179 thorough larger vessels, 201 204
Kirchhoff’s laws, 10 11 Magnetic energy density, 4
Kirchhoff’s theorem, 222 Magnetic field, 172, 178
work interactions, 278 280
L Magnetic field therapy (MFT), 239
Lagrange polynomials, 13 modeling, 240 242
Landau Ginzburg model, 112, 114 115 numerical simulation results, 242 244
Laplace equation, 9 10, 113 114 Magnetic flux law, 8 9
“Lengthening” effect, 96 Magnetic forces, 197
“LeVeen” array of electrodes, 257 Magnetic hyperthermia, 277 283
Level set method, 179 magnetic field work interactions, 278 280
Ligands, 174 microwave magnetic thermal thermotherapy of
Liver, 254 hepatic tumor, 280 283
Living trees, 51 54 Magnetic nanoparticles (MNPs), 171, 252
Local hyperthermia (LH), 250 for MDT, 173 177
Long cell fibers, 220 230 magnetic properties of materials, 173 174
Low action potentials (Low AP), 94 SPIONs, 174 176
Lower divisions (LD divisions), 255 256 Magnetic Resonance guided High Intensity
Lumbar magnetic stimulation (LMS), 219. See also Focused Ultrasound (MRgHIFU),
Transcranial magnetic stimulation (TMS) 283 284
modeling, 230 233 Magnetic Resonance Imaging (MRI), 30, 73 74,
Lumped electric circuit models, 146 153, 254
Magnetic scalar potential, 185
M Magnetic stimulation (MS), 217 218
Maghemite (γ-Fe 2 O 3 ), 174 of long cell fibers, reduced mathematical model,
Magnetic drift coefficient, 204 205 220 230
Magnetic drug mixing, 179 180 activating function produced by circular coils,
Magnetic drug targeting (MDT), 171 225 227
from blood vessel to targeted region, 180 198 activation function distribution inside body,
conceptual to more realistic models, 194 198 227 230
constructal optimization of magnetic field cable theory and activating function,
source, 185 191 220 223
electromagnets, 191 194 computational model for induced electric
hemodynamic and magnetic field driven mass field and activating function, 223 225
transfer in larger vessels, 182 185 magnetic therapy, 239 244
magnetic drug mixing, 179 180 of spinal cord, 230 234
magnetic drug transfer from larger blood vessel TMS, 234 239
to region of interest, 199 210 Magnetic therapy, 239 244
MNPs for, 173 177 Magnetic vector potential, 183
magnetic properties of materials, 173 174 Magnetic velocity, 205, 210
SPIONs, 174 176 Magnetite (Fe 3 O 4 ), 174
modeling concerns in, 177 178 Magnetizable aggregate fluid (MAF), 179
Magnetic drug transfer Magnetotherapy (MT), 220
biorheological models in magnetic drug transfer, Mass
199 200 conservation law, 61, 258